Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -0.67% | +2.07% | +2.07% |
Mar. 12 | Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer as Chief Medical Officer | CI |
Mar. 07 | Citigroup Adjusts Rigel Pharmaceuticals' Price Target to $4 From $3, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 148M | Sales 2025 * | 181M | Capitalization | 260M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 10M | EV / Sales 2024 * | 1.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.43 x |
P/E ratio 2024 * |
-19.1
x | P/E ratio 2025 * |
26.7
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Rigel Pharmaceuticals, Inc.
1 day | -0.67% | ||
1 week | +2.07% | ||
Current month | -2.63% | ||
1 month | -4.52% | ||
3 months | -5.13% | ||
6 months | +32.14% | ||
Current year | +2.07% |
Managers | Title | Age | Since |
---|---|---|---|
Raul Rodriguez
CEO | Chief Executive Officer | 63 | 00-03-31 |
Dean Schorno
DFI | Director of Finance/CFO | 61 | 18-05-28 |
Chief Tech/Sci/R&D Officer | - | 16-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 17-11-01 |
Gary Lyons
BRD | Director/Board Member | 73 | 05-09-30 |
Raul Rodriguez
CEO | Chief Executive Officer | 63 | 00-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 464 M€ | -.--% | ||
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.48 | -0.67% | 782,389 |
24-03-27 | 1.49 | +4.93% | 681,287 |
24-03-26 | 1.42 | -1.39% | 349,056 |
24-03-25 | 1.44 | +1.41% | 800,395 |
24-03-22 | 1.42 | -2.07% | 768,071 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.07% | 260M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |